Seres Therapeutics, Inc. Accumulated Other Comprehensive Income
Seres Therapeutics, Inc. (MCRB) had Accumulated Other Comprehensive Income of $0 as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-11-05
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-05 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-13 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$1.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$12.00K 8-K · filed 2024-08-15 |
| 2022-09-30 | -$118.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | -$256.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$215.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$60.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $11.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $12.00K 10-Q · filed 2021-08-03 |
| 2021-03-31 | -$15.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | -$47.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.00K 10-Q · filed 2020-07-28 |
| 2020-03-31 | -$10.00K 10-Q · filed 2020-05-07 |
| 2019-09-30 | $7.00K 10-Q · filed 2019-11-05 |
| 2018-09-30 | -$9.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$29.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$106.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$146.00K 10-K · filed 2019-03-06 |
| 2017-09-30 | -$99.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$176.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$151.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | -$149.00K 10-K · filed 2018-03-08 |
| 2016-09-30 | -$67.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $83.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $108.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $30.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | -$10.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $23.00K 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |